| Company Name: |
TargetMol |
| Tel: |
400-821-0310 15002144251 |
| Email: |
xuexiang.shao@tsbiochem.com |
|
| | Tricyclo[3.3.1.13,7]decane-2-carboxylic acid, 2-[[[5-(2,6-dimethoxyphenyl)-1-[2-(1-methylethyl)-4-[[methyl[3-[methyl[3-(methylamino)propyl]amino]propyl]amino]carbonyl]phenyl]-1H-pyrazol-3-yl]carbonyl]amino]- Basic information |
| | Tricyclo[3.3.1.13,7]decane-2-carboxylic acid, 2-[[[5-(2,6-dimethoxyphenyl)-1-[2-(1-methylethyl)-4-[[methyl[3-[methyl[3-(methylamino)propyl]amino]propyl]amino]carbonyl]phenyl]-1H-pyrazol-3-yl]carbonyl]amino]- Chemical Properties |
| Boiling point | 867.1±65.0 °C(Predicted) | | density | 1.27±0.1 g/cm3(Predicted) | | pka | 3.28±0.20(Predicted) |
| | Tricyclo[3.3.1.13,7]decane-2-carboxylic acid, 2-[[[5-(2,6-dimethoxyphenyl)-1-[2-(1-methylethyl)-4-[[methyl[3-[methyl[3-(methylamino)propyl]amino]propyl]amino]carbonyl]phenyl]-1H-pyrazol-3-yl]carbonyl]amino]- Usage And Synthesis |
| Uses | SR 142948-C3-NHMe is the methylated SR 142948 (HY-107664). | | References | [1] Renard E, et al. Positron Emission Tomography Imaging of Neurotensin Receptor-Positive Tumors with 68Ga-Labeled Antagonists: The Chelate Makes the Difference Again. J Med Chem. 2021 Jun 24;64(12):8564-8578. DOI:10.1021/acs.jmedchem.1c00523 |
| | Tricyclo[3.3.1.13,7]decane-2-carboxylic acid, 2-[[[5-(2,6-dimethoxyphenyl)-1-[2-(1-methylethyl)-4-[[methyl[3-[methyl[3-(methylamino)propyl]amino]propyl]amino]carbonyl]phenyl]-1H-pyrazol-3-yl]carbonyl]amino]- Preparation Products And Raw materials |
|